MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-HP-11-0013184
Samson Laboratories Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹67.3 Cr
▲ 13% YoY
Net profit · FY 2025
₹1.31 Cr
Net margin 2%
EBITDA · FY 2025
₹4.73 Cr
EBITDA margin 7%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹17 Lakh
Issued & subscribed
Open charges
₹22.86 Cr
Satisfied ₹23.8 Cr
Company age
41 yrs
Est. 1985
Directors on board
3
As per MCA filings
About Samson Laboratories Private Limited
Data last updated:
Samson Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 February 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1985PTC020099. Its GSTIN is 07AAACS1471Q1Z0 (Delhi). The company holds 4 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹17 Lakh. It is led by directors including Harish Goyal and Dipu Katiyar.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.37 Ground Floor Pocket N Sector – 5 Bawana Dsidc Landmark Near Cng Pump Delhi, Delhi, India – 110039.
As per the financials filed for FY 2025, the company reported a revenue of ₹67.3 Cr, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹1.31 Cr (net margin 2%) and EBITDA of ₹4.73 Cr (EBITDA margin 7%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹22.86 Cr and satisfied charges of ₹23.8 Cr on record. Court records list 193 cases involving the company, including 163 filed by the company and 30 filed against it; 53 cases are pending. The company has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹32.5 Lakh; the latest was in December 2017. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Super Lifecare Private Limited with revenue of ₹68.31 Cr.
Samson Laboratories Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0013184). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website samsonlab.co.in.
Company details
CIN U74899DL1985PTC020099
Registration Number 020099
Incorporation Date 11 February 1985
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HP-11-0013184
Recognitions & Rankings of Samson Laboratories
Contact details
Samson Laboratories Private Limited's registered office is in Delhi, Delhi. Its website is samsonlab.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.37 Ground Floor Pocket N Sector – 5 Bawana Dsidc Landmark Near Cng Pump Delhi, Delhi, India – 110039
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Samson Laboratories Private Limited, buy the company report.
Comprehensive company report
Samson Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Samson Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Samson Laboratories Private Limited, buy the company report.
Financials of Samson Laboratories Private Limited
FY 2024 filings availableSamson Laboratories Private Limited reported revenue of ₹67.3 Cr (up 13% YoY) for FY 2025.
Revenue · FY 2025
₹67.3 Cr ▲ 13%
Net profit · FY 2025
₹1.31 Cr margin 2%
EBITDA · FY 2025
₹4.73 Cr margin 7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 13%
3 years · compounded
▼ 7%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▲ 22%
3 years · compounded
▲ 6%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 13% growth in the latest year. EBITDA rose 22% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.73 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.31 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7% | ||||
| Net Profit Margin | 2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Samson Laboratories Private Limited, buy the company report.
Board of directors of Samson Laboratories Private Limited
Samson Laboratories has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Harish Goyal Also directs: Niv Lifesciences LLP, Medilia Limited | Director | 16 Sep 1995 | 31 Years 1 Months | Current |
| Dipu Katiyar | Director | 04 Nov 2023 | 2 Years 11 Months | Current |
| Suneel Kumar | Additional Director | 21 Nov 2025 | 0 Years 11 Months | Current |
Peer comparison
Samson Laboratories Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Super Lifecare Private Limited | ₹68.31 Cr (FY 2025) | -16.0% | Ahmedabad, Gujarat, India | |||
| Oxford Laboratories Private Limited | ₹67.77 Cr (FY 2025) | 26.0% | Mumbai, Maharashtra, India | |||
| Beloorbayir Biotech Limited | ₹67.42 Cr (FY 2021) | -4.0% | Bangalore, Karnataka, India | |||
| United Bioceuticals Private Limited | ₹67.35 Cr (FY 2024) | 31.0% | New Delhi, Delhi, India | |||
| Samson Laboratories Private Limitedthis company | ₹67.3 Cr (FY 2025) | ₹1.31 Cr | 2% | 13.0% | Delhi, India | |
| Premium Serums and Vaccines Private Limited | ₹67.25 Cr (FY 2025) | 28.0% | Mumbai, Maharashtra, India | |||
| Pharmax India Private Limited | ₹66.65 Cr (FY 2024) | 2.0% | Mumbai, Maharashtra, India | |||
| Swefn Pharmaceuticals Private Limited | ₹66.63 Cr (FY 2025) | 9.0% | Moraiya, Gujarat, India |
To see the full peer comparison of Samson Laboratories Private Limited, buy the company report.
Auditor
Samson Laboratories Private Limited is audited by DALIP SACHDEVA & ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| DALIP SACHDEVA & ASSOCIATES | FY 2022 | 018155N |
Shareholding
The shareholding of Samson Laboratories Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Samson Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹22.86 Cr
Satisfied charges
₹23.8 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 20 May 2024 | 100935180 | Others | ₹2.5 Cr | Open | |
| 09 Dec 2021 | 100518883 | Others | ₹1.2 Cr | Open | |
| 08 Oct 2021 | 100490995 | Hdfc Bank Limited | ₹30 Lakh | Open | |
| 03 Dec 2019 | 100326297 | Others | ₹14 Cr | Open | |
| 03 Dec 2019 | 100326296 | Others | ₹2.86 Cr | Open |
To see the full charge records of Samson Laboratories Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Samson Laboratories Private Limited has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹32.5 Lakh; the latest was in December 2017.
Total deals
4
Secondary share transfers
3
Funding round
1
Disclosed funding
₹32.5 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2017 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Anukam Investment Leasing Finance Private Limited , 3 individuals |
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Anukam Investment Leasing Finance Private Limited , 3 individuals Seller: 4 individuals |
| Mar 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: J.R Goyal HUF, an individual |
| Mar 2009 | Funding round | ₹32.5 Lakh | Investors: Sumnex Mercantile Pvt Ltd , Negus Distributors Pvt Ltd , Ornamental Fabrications Pvt Ltd , an individual |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Samson Laboratories Private Limited has 193 court cases on record: 163 filed by Samson Laboratories, 30 filed against it. 53 cases are pending and 140 are disposed.
Total cases
193
Filed by the company
163
Filed against the company
30
Pending
53
Disposed
140
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 177 | 18 | 49 |
| High courts | 16 | 12 | 4 |
Cases on record (5 of 193)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Franco-Indian Pharmaceuticals Pvt Ltd | Pending |
| High Court, TAMIL NADU | Original application | Filed against the company by M/S. Apex Laboratories Pvt Ltd | Pending |
| High Court, TAMIL NADU | Appeal | Filed against the company by M/S. Apex Laboratories Pvt Ltd | Disposed |
| High Court, TAMIL NADU | Civil suit | Filed against the company by M/S. Apex Laboratories Pvt Ltd and 2 others | Disposed |
| Madras High Court | Appeal | Filed against the company by Growmax Medicare Pvt.Ltd. | Disposed |
To see the full case history of Samson Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Samson Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Samson Laboratories has 4 GST registrations: 2 active and 2 cancelled or inactive.
Total GSTINs
4
Active
2
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACS1471Q1Z0 | Delhi | Active | 01 Jul 2017 |
| 02AAACS1471Q1ZA | Himachal Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Samson Laboratories Private Limited, buy the company report.
Recent activity
Samson Laboratories Private Limited has 9 board changes on record since 1995: 3 appointments and 6 cessations. The latest: Suneel Kumar was appointed as Additional Director on 21 Nov 2025.
Appointed
Suneel Kumar was appointed as Additional Director.
AGM
Samson Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 2.50 Cr with Charge ID 100935180 was registered on 20 May 2024.
Charges
A charge with Others of Rs. 14.00 Cr registered on 03 Dec 2019 with Charge ID 100326297 was modified on 20 May 2024.
Filing
Samson Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Ceased
Manoj Kumar Sharma ceased to be Director.
Appointed
Dipu Katiyar was appointed as Director.
Charges
A charge registered on 02 Nov 2022 via Charge ID 100704621 with Hdfc Bank Limited was fully satisfied on 29 Sep 2023.
Charges
A charge registered on 15 Mar 2011 via Charge ID 10316198 with Bank Of Baroda was fully satisfied on 28 Dec 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 18.00 Cr with Charge ID 100704621 was registered on 02 Nov 2022.
Charges
A charge with Others amounted to Rs. 1.20 Cr with Charge ID 100518883 was registered on 09 Dec 2021.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 0.30 Cr with Charge ID 100490995 was registered on 08 Oct 2021.
21 earlier events are in the company report.
Frequently asked questions
Samson Laboratories is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 February 1985 (41+ years old) and is registered under CIN U74899DL1985PTC020099.
Samson Laboratories has 3 current directors:
- Harish Goyal - Director
- Dipu Katiyar - Director
- Suneel Kumar - Additional Director
The latest financial statements of Samson Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Samson Laboratories is 07AAACS1471Q1Z0, registered in Delhi. The company has 4 GST registrations in all, of which 2 are active and 2 are cancelled or inactive. Other active GSTINs include 02AAACS1471Q1ZA (Himachal Pradesh).
The CIN (Corporate Identification Number) of Samson Laboratories is U74899DL1985PTC020099. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Samson Laboratories has 193 court cases on record: 163 filed by the company and 30 filed against it. 53 are pending. Most are in the district courts.
Samson Laboratories was incorporated on 11 February 1985, making it 41+ years old. It is registered with the Registrar of Companies, Delhi.
Samson Laboratories has 4 deals on record (3 secondary share transfers, 1 funding round), with disclosed funding of ₹32.5 Lakh; the latest was in December 2017.
The peers of Samson Laboratories by revenue are Super Lifecare Private Limited, Oxford Laboratories Private Limited, Beloorbayir Biotech Limited, United Bioceuticals Private Limited, Premium Serums and Vaccines Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Suneel Kumar was appointed as Additional Director on 21 Nov 2025. Manoj Kumar Sharma ceased to be Director on 05 Nov 2023. Dipu Katiyar was appointed as Director on 04 Nov 2023. Samson Laboratories has 9 board changes on record in total.
Yes, Samson Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HP-11-0013184).